检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Robin Kate Kelley,Lorenza Rimassa,Ann-Lii Cheng,Ahmed Kaseb,Shukui Qin,Andrew X Zhu,Stephen L Chan,Tamar Melkadze,Wattana Sukeepaisarnjaroen,Valery Breder,Gontran Verset,Edward Gane,Ivan Borbath,Jose David Gomez Rangel,Baek-Yeol Ryoo,Tamta Makharadze,Philippe Merle,Fawzi Benzaghou,Kamalika Banerjee,Saswati Hazra, Jonathan Fawcett,Thomas Yau

The Lancet Oncology（2022）

引用 173|浏览43
暂无评分
摘要
Exelixis and Ipsen.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要